Literature DB >> 34424329

RE: Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study.

Chen Nahshon1, Ofer Lavie1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 34424329      PMCID： PMC8826471          DOI： 10.1093/jnci/djab154

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   11.816


× No keyword cloud information.
  7 in total

1.  Frequent Homologous Recombination Deficiency in High-grade Endometrial Carcinomas.

Authors:  Marthe M de Jonge; Aurélie Auguste; Lise M van Wijk; Philip C Schouten; Matty Meijers; Natalja T Ter Haar; Vincent T H B M Smit; Remi A Nout; Mark A Glaire; David N Church; Harry Vrieling; Bastien Job; Yannick Boursin; Cor D de Kroon; Etienne Rouleau; Alexandra Leary; Maaike P G Vreeswijk; Tjalling Bosse
Journal:  Clin Cancer Res       Date:  2018-11-09       Impact factor: 12.531

2.  The clinical characteristics and prognosis of endometrial carcinomas that occur after breast cancer: does hormone receptor status of breast cancer matter?

Authors:  Jianbin Guo; Ying Zhang; Haili Qian; Fei Ma; Xiujuan Cui; Hua Duan
Journal:  Arch Gynecol Obstet       Date:  2019-10-01       Impact factor: 2.344

3.  Should the risk for uterine cancer influence decision making for prophylactic hysterectomy in BRCA1/2 mutated patients- a systematic review and meta-analysis.

Authors:  Chen Nahshon; Yakir Segev; Ofer Gemer; Tomer Bar Noy; Meirav Schmidt; Ludmila Ostrovsky; Ofer Lavie
Journal:  Gynecol Oncol       Date:  2020-12-10       Impact factor: 5.482

4.  Association between uterine serous carcinoma and breast cancer.

Authors:  Paola A Gehrig; Victoria L Bae-Jump; John F Boggess; Pamela A Groben; Wesley C Fowler; Linda Van Le
Journal:  Gynecol Oncol       Date:  2004-07       Impact factor: 5.482

5.  BRCA1/2 and Endometrial Cancer Risk: Implications for Management.

Authors:  Mark E Sherman; William D Foulkes
Journal:  J Natl Cancer Inst       Date:  2021-09-04       Impact factor: 13.506

6.  Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study.

Authors:  Marthe M de Jonge; Cornelis D de Kroon; Denise J Jenner; Jan Oosting; Joanne A de Hullu; Marian J E Mourits; Encarna B Gómez Garcia; Margreet G E M Ausems; J Margriet Collée; Klaartje van Engelen; Irma van de Beek; Vincent T H B M Smit; Matti A Rookus; Geertruida H de Bock; Flora E van Leeuwen; Tjalling Bosse; Olaf M Dekkers; Christi J van Asperen
Journal:  J Natl Cancer Inst       Date:  2021-09-04       Impact factor: 13.506
  7 in total
  1 in total

1.  Response to Nahshon and Lavie.

Authors:  Cornelis D de Kroon; Marthe M de Jonge; Tjalling Bosse; Christi J van Asperen
Journal:  J Natl Cancer Inst       Date:  2022-02-07       Impact factor: 11.816
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.